ViBA

Improving Individualized Salbutamol Treatment: A Population Pharmacokinetic Model for Oral Salbutamol in Virtual Patients.

Marques L, Vale N. · Pharmaceutics · 2024 · Article

10.3390/pharmaceutics17010039

Verified evidence

Baseline pharmacokinetic model comparison

007f37e5-7402-5c8c-a8d2-da75de72e2de
Pharmacokinetics and drug exposure

Prediction source Version of record · PDF page(s) 7

Study 46beea96-343c-59c1-9ab6-feca0e7c311d · Prediction record (JSON)

Prediction fields

Comparator
experimental_or_observational_reference · PDF page(s) 7
Concrete comparator
healthy reference model · PDF page(s) 7
Endpoint
pk_parameter_panel_cmax_tmax_auc__fold_deviation_within_twofold · PDF page(s) 7
Family
pharmacokinetic_exposure · PDF page(s) 7
Measured variable
pk_parameter_panel_cmax_tmax_auc · PDF page(s) 7
Measurement role
prediction_error · PDF page(s) 7
Metric
fold_deviation_within_twofold · PDF page(s) 7
Model
mechanistic_or_numerical · PDF page(s) 1, 7
Reference type
observed_clinical_reference · PDF page(s) 7
Role
prediction_error · PDF page(s) 7
Scenario
single_dose_virtual_healthy_example · PDF page(s) 7

Validation Direct comparison · Unknown · Unknown · Partial support · Partially comparable · Not applicable